Rachel Jordanpublicó una nota 4 months ago

Hit to Lead for the Antiviral Drug Discovery of Coronavirus

At present, the drug research for treating Coronavirus Disease 2019 (COVID-19) has just started, and there is a lack of selective therapeutic drugs in clinical practice. It is urgent to find and develop new treatment methods and drugs. In the face of urgent outbreaks, it is an efficient strategy to screen potential drug candidates from old drugs that are already on the market or from active molecules in clinical trials. Considering the threat of coronavirus infection to humans, we should not only actively seek specific antiviral drugs, but also promote the development of new broad-spectrum anti-coronavirus drugs. After hit identification, Creative Biostructure provides a full range of <a href="https://www.creative-biostructure.com/coronavirus/hit-to-lead-for-the-antiviral-drug-discovery-of-coronavirus-p22.htm">hit-to-lead services</a> to support your antiviral drug discovery project against coronavirus infection.

By using a parallel evaluation approach, the process of hit to lead can be accelerated. Through this phase, the range of compounds requiring further optimization is narrowed. After discussions with the customer, scientists at Creative Biostructure will ultimately determine whether these hits are suitable for subsequent optimization studies. Our customer service representative is available 24 hours a day from Monday to Sunday. If you have any questions, please feel free to contact us.